Anticytomegalovirus T-cell clones - Reply

[1] BOECKH M, 1992, BLOOD, V80, P1358

[2] Boeckh M, 1995, Cancer Treat Res, V76, P97

[3] EINSELE H, 1995, BLOOD, V86, P2815

[4] DELAYED INFUSION OF IMMUNOCOMPETENT DONOR CELLS AFTER BONE-MARROW TRANSPLANTATION BREAKS GRAFT-HOST TOLERANCE AND ALLOWS FOR PERSISTENT ANTILEUKEMIC REACTIVITY WITHOUT SEVERE GRAFT-VERSUS-HOST DISEASE [J]. BLOOD, 1995, 85 (11) : 3302 - 3312

[5] USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION [J]. LANCET, 1995, 345 (8941) : 9 - 13

[1] BOECKH M, 1992, BLOOD, V80, P1358

[2] Boeckh M, 1995, Cancer Treat Res, V76, P97

[3] EINSELE H, 1995, BLOOD, V86, P2815

[4] DELAYED INFUSION OF IMMUNOCOMPETENT DONOR CELLS AFTER BONE-MARROW TRANSPLANTATION BREAKS GRAFT-HOST TOLERANCE AND ALLOWS FOR PERSISTENT ANTILEUKEMIC REACTIVITY WITHOUT SEVERE GRAFT-VERSUS-HOST DISEASE [J]. BLOOD, 1995, 85 (11) : 3302 - 3312

[5] USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION [J]. LANCET, 1995, 345 (8941) : 9 - 13